High D-dimer levels are associated with poor prognosis in cancer patients
about
Impact of d-Dimers on the Differential Diagnosis of Acute Chest Pain: Current Aspects Besides the Widely KnownIncidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective studyD-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patientsEvaluation of plasma D-dimer plus fibrinogen in predicting acute CVST.A retrospective analysis of plasma D-dimer dynamic variation in terminal stage cancer patients: implications for disease progressionQuality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients.Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma.Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control studyImpact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.D-Dimer elevation and adverse outcomesPlatelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism.Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients.High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor ExtensionClinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast CancerHigh Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by ChemotherapyTumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study.D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer.Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomyCancer-associated thrombosis: clinical presentation and survival.Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study.High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patientsClinical models and biochemical predictors of VTE in lung cancer.Air quality improvement during 2010 Asian games on blood coagulability in COPD patients.Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 2--Lower airway, thromboembolic, and inflammatory diseases.Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer.Widely Used Types and Clinical Applications of D-Dimer Assay.Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer.Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study.Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.Fibrinogen and D-dimer levels elevate in advanced hepatocellular carcinoma: High pretreatment fibrinogen levels predict poor outcomes.D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.Excess long-term mortality in outpatient deep venous thrombosis patients managed in an ambulatory care setting.Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation productsFibrinogen and D-dimer levels in prostate cancer: Preliminary resultsElevated serum creatinine and low albumin are associated with poor outcomes in patients with liposarcoma.Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.A high plasma D-dimer level predicts poor prognosis in gynecological tumors in East Asia area: a systematic review and meta-analysis.
P2860
Q27011905-2863FE98-3059-4B78-8284-A53445A706E6Q33560114-EDF0628C-5C08-4231-8A93-5C5F9FE31FAAQ33830926-9306D436-6415-49A8-91B0-E10034592442Q34090327-14F09F5E-38F4-4F55-9B3D-92158DE6023CQ34167387-74260125-6313-48EC-AE66-4015E54AD350Q34343801-BDFD2A58-B527-420E-A6ED-F8FF144125CCQ34565533-D8C5F9C2-0E96-4901-A8EF-055D7AC0121BQ34611568-693473A8-7821-4695-AAB5-2215DA265F84Q34893956-F28F53B1-8A5A-4E20-B331-CD3CC83927BBQ34990303-DEF0ADB3-F9F5-45E5-ACC0-EA6C02A608CFQ35110810-95CAF360-3EBC-4300-BFCD-595ACED43ED2Q35117857-A83125DA-F29A-4E3C-98EB-4720E764E892Q35529221-898D1366-351F-4C10-A372-DEDC79CDA499Q35901137-2BC9B82F-A2C1-4324-94C8-8B7FB75DC308Q35975572-80FC626C-CD2E-4EBD-8674-EC482E069AB9Q35988386-B7667AEE-8996-440D-BC73-2C415C81531CQ36009299-C99FFC36-F99E-433B-9EBA-D016C1CDE3C6Q36189708-9D53892E-6DA3-4629-8154-23D7C1D88422Q36249338-A4057DFE-F2A5-4E45-BD03-38B6F6E9D162Q36454673-DD6287E8-E8B7-4C87-9060-CF7759C35742Q37066546-69A2242C-46BC-4E65-898A-F4590D2F747DQ37144916-E08148A9-CCF2-4FF5-BEE0-453363176975Q37185806-B6945861-7094-4577-9523-BEC865BA4825Q38205701-6F419A3F-0A27-43F9-A52E-880F7E78FB3CQ38410883-75A22AC3-6629-4C3B-B09E-AE6999DFF3B9Q38514907-307661AA-312C-4C64-9A53-CF5D8D4A0825Q38669760-C049C2F1-5435-4196-AEC5-CF230C4B0215Q38789567-5C18E6D3-7B9D-49D3-90A3-487BDF90D56AQ39201228-40758538-41C7-4792-9C79-2B719A3C84BEQ39683672-A5626A61-CA92-482E-AB0D-6036C74CE937Q40040117-8F912D5E-83B8-4D5E-96DD-4BF2495E809EQ40217071-2450A193-AFCB-49DB-8BDE-55F20823A078Q40425505-D6A0753C-AED7-4AA6-A64F-26628C40EF0AQ40489634-0373EB29-CC8C-4C2A-A5C8-9FCA55EE5C9FQ40628993-F346EB22-D775-4EEE-A239-BE7771CD7B58Q40875276-F8D84771-3B2E-453A-871D-8861DC4DC307Q41345857-4BB0516B-1F1F-4C4F-98E3-1161E6D88EDEQ41534599-F0EEFA41-4751-4BEF-A755-3FB53CCC9C1BQ41577287-FFF662E1-E62E-470B-8568-7A3FC6624127Q41612883-59BEDE21-4637-48F4-B47A-67C85DC468C0
P2860
High D-dimer levels are associated with poor prognosis in cancer patients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High D-dimer levels are associated with poor prognosis in cancer patients
@ast
High D-dimer levels are associated with poor prognosis in cancer patients
@en
type
label
High D-dimer levels are associated with poor prognosis in cancer patients
@ast
High D-dimer levels are associated with poor prognosis in cancer patients
@en
prefLabel
High D-dimer levels are associated with poor prognosis in cancer patients
@ast
High D-dimer levels are associated with poor prognosis in cancer patients
@en
P2093
P2860
P50
P1433
P1476
High D-dimer levels are associated with poor prognosis in cancer patients
@en
P2093
Christoph Zielinski
Daniela Dunkler
Johannes Thaler
Oswald Wagner
Robert Pirker
P2860
P304
P356
10.3324/HAEMATOL.2011.054718
P577
2012-02-27T00:00:00Z